Carbapenem Resistance in Enterotoxigenic Bacteroides fragilis Isolated From Colonoscopy Candidates [PDF]
AMB ExpressThe present study aimed to determine the carbapenem resistance among Enterotoxigenic Bacteroides fragilis (ETBF) isolated from patients candidates to colonoscopy in Shiraz, Iran. A total of 201 stool samples were gathered from 201 patients. The detection
Ebrahim Fallahzadeh, Taher Azimi
exaly +3 more sources
Prevalence of Enterotoxigenic Bacteroides fragilis in Patients With Colorectal Cancer: A Systematic Review and Meta-Analysis [PDF]
Frontiers in Cellular and Infection MicrobiologyIntroductionThe gut microbiome, specifically enterotoxigenic Bacteroides fragilis (ETBF), has been reported to play a role in colorectal cancer development.
Linchong Yu
exaly +4 more sources
KRAS Mutations Promote the Intratumoral Colonization of Enterotoxigenic Bacteroides Fragilis in Colorectal Cancer Through the Regulation of the miRNA3655/SURF6/IRF7/IFNβ Axis [PDF]
Gut MicrobesKRAS mutations are associated with poor prognosis in colorectal cancer (CRC). Although the association between the gut microbiota and CRC has been extensively documented, it is unclear whether KRAS mutations can regulate the gut microbiota.
Yizhen Chen +2 more
exaly +4 more sources
Evaluation of enterotoxigenic Bacteroides fragilis correlation with the expression of cellular signaling pathway genes in Iranian patients with colorectal cancer [PDF]
Infectious Agents and Cancer, 2023 Background Colorectal cancer (CRC) is one of the most common cancers all over the world, and dysbiosis in the gut microbiota may play a role in colorectal carcinogenesis.
Leila Dadgar-Zankbar +7 more
doaj +2 more sources
Prevalence of pks + bacteria and enterotoxigenic Bacteroides fragilis in patients with colorectal cancer [PDF]
Gut Pathogens, 2022 Background Colorectal cancer (CRC) is the third most diagnosed cancer and the second most common cause of cancer deaths worldwide. CRC patients present with an increase in pathogens in their gut microbiota, such as polyketide synthase-positive bacteria ...
Manon Oliero +13 more
doaj +2 more sources
G-protein coupled receptor 35 (GPR35) regulates the colonic epithelial cell response to enterotoxigenic Bacteroides fragilis [PDF]
Communications Biology, 2021 Boleij et al. show that G protein-coupled receptor 35 (GPR35) regulates the responses to enterotoxigenic Bacteroides fragilis (ETBF) in colonic epithelial cells.
Annemarie Boleij +14 more
doaj +2 more sources
Enterotoxigenic Bacteroides fragilis activates IL-8 expression through Stat3 in colorectal cancer cells [PDF]
Gut Pathogens, 2022 Background Enterotoxigenic Bacteroides fragilis (ETBF) has been implicated in colorectal carcinogenesis through the actions of its toxin, B. fragilis toxin (BFT).
Rachel V. Purcell +2 more
doaj +2 more sources
In Vitro Evaluation of the Therapeutic Potential of Phage VA7 against Enterotoxigenic Bacteroides fragilis Infection [PDF]
Viruses, 2021 Since the beginning of the 20th century, bacteriophages (phages), i.e., viruses that infect bacteria, have been used as antimicrobial agents for treating various infections. Phage preparations targeting a number of bacterial pathogens are still in use in
Nata Bakuradze +12 more
doaj +2 more sources
Frontiers in Cellular and Infection Microbiology, 2020 Enterotoxigenic Bacteroides fragilis (ETBF) produces Bacteroides fragilis toxin (BFT), which is associated with acute diarrheal, inflammatory bowel disease, and colorectal cancer (CRC).
Samin Zamani +2 more
exaly +3 more sources
Biological Mechanisms of Enterotoxigenic Bacteroides fragilis Toxin: Linking Inflammation, Colorectal Cancer, and Clinical Implications [PDF]
ToxinsEnterotoxigenic Bacteroides fragilis (ETBF) has emerged as a gut microbiome pathogen that can promote intestinal inflammation and contribute to colorectal cancer (CRC).
Seyedesomaye Jasemi +5 more
doaj +2 more sources